Eli Lilly & Co plans to invest £279 million ($364 million) in a new initiative to support UK biotechs along with a study of ...

Health Innovation Manchester and The University of Manchester has today (14 October 2024) announced a groundbreaking ...

PepsiCo and other snack stocks are suffering as households cut costs. Why tiny Utz Brands looks like a better buy.

Giving older Americans access to weight-loss medicines through the US Medicare program would cost $35 billion over nine years ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

Medicare is prohibited by law from covering GLP-1 drugs for weight loss. But many beneficiaries can access the drugs anyway.

A review of the recent evidence suggests that GLP-1 drugs, such as semaglutide, could protect brain health and cognitive ...

France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.View on ...

Popular weight loss drugs are so pricey that many may shell out hundreds or even thousands of dollars on them. Some ...

Ilant estimates that behavioral therapy can help many people lose up to 5% of their weight, anti-obesity medications can help ...

PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...

Achieving weight loss within a year of initiating orlistat can reduce the risk for both incident gout and recurrent gout ...